Annual Current Assets
$1.91 B
+$55.05 M+2.97%
December 31, 2023
Summary
- As of February 7, 2025, CRSP annual total current assets is $1.91 billion, with the most recent change of +$55.05 million (+2.97%) on December 31, 2023.
- During the last 3 years, CRSP annual current assets has risen by +$191.46 million (+11.15%).
- CRSP annual current assets is now -21.07% below its all-time high of $2.42 billion, reached on December 31, 2021.
Performance
CRSP Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$1.94 B
-$66.52 M-3.31%
September 30, 2024
Summary
- As of February 7, 2025, CRSP quarterly total current assets is $1.94 billion, with the most recent change of -$66.52 million (-3.31%) on September 30, 2024.
- Over the past year, CRSP quarterly current assets has increased by +$35.81 million (+1.88%).
- CRSP quarterly current assets is now -25.83% below its all-time high of $2.62 billion, reached on June 30, 2021.
Performance
CRSP Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
CRSP Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.0% | +1.9% |
| 3 y3 years | +11.2% | -22.8% |
| 5 y5 years | +309.1% | +192.7% |
CRSP Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.1% | +3.0% | -19.6% | +10.4% |
| 5 y | 5-year | -21.1% | +93.2% | -25.8% | +109.2% |
| alltime | all time | -21.1% | >+9999.0% | -25.8% | +1139.4% |
CRISPR Therapeutics AG Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.94 B(-3.3%) |
| Jun 2024 | - | $2.01 B(-5.2%) |
| Mar 2024 | - | $2.12 B(+11.1%) |
| Dec 2023 | $321.49 M(-17.6%) | $1.91 B(+8.4%) |
| Sep 2023 | - | $1.76 B(-5.3%) |
| Jun 2023 | - | $1.86 B(-2.5%) |
| Mar 2023 | - | $1.91 B(+3.0%) |
| Dec 2022 | $390.03 M(+16.6%) | $1.85 B(-4.1%) |
| Sep 2022 | - | $1.93 B(-8.3%) |
| Jun 2022 | - | $2.11 B(-6.8%) |
| Mar 2022 | - | $2.26 B(-6.5%) |
| Dec 2021 | $334.36 M(+200.3%) | $2.42 B(-4.0%) |
| Sep 2021 | - | $2.52 B(-3.9%) |
| Jun 2021 | - | $2.62 B(+43.0%) |
| Mar 2021 | - | $1.83 B(+6.7%) |
| Dec 2020 | $111.35 M | $1.72 B(+23.4%) |
| Sep 2020 | - | $1.39 B(+44.0%) |
| Jun 2020 | - | $965.62 M(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $929.28 M(-5.9%) |
| Dec 2019 | $79.20 M(+250.1%) | $987.55 M(+48.7%) |
| Sep 2019 | - | $664.07 M(+51.4%) |
| Jun 2019 | - | $438.47 M(-2.5%) |
| Mar 2019 | - | $449.80 M(-3.6%) |
| Dec 2018 | $22.62 M(-1.5%) | $466.39 M(-6.1%) |
| Sep 2018 | - | $496.69 M(+50.3%) |
| Jun 2018 | - | $330.55 M(-6.0%) |
| Mar 2018 | - | $351.48 M(+41.5%) |
| Dec 2017 | $22.96 M(-7.3%) | $248.38 M(-3.9%) |
| Sep 2017 | - | $258.59 M(-8.1%) |
| Jun 2017 | - | $281.29 M(-5.1%) |
| Mar 2017 | - | $296.46 M(-7.4%) |
| Dec 2016 | $24.77 M(+859.1%) | $320.19 M(+38.2%) |
| Sep 2016 | - | $231.65 M(-7.0%) |
| Jun 2016 | - | $249.16 M(+58.9%) |
| Dec 2015 | $2.58 M(+362.1%) | $156.84 M |
| Dec 2014 | $559.00 K | - |
FAQ
- What is CRISPR Therapeutics AG annual total current assets?
- What is the all time high annual current assets for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual current assets year-on-year change?
- What is CRISPR Therapeutics AG quarterly total current assets?
- What is the all time high quarterly current assets for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly current assets year-on-year change?
What is CRISPR Therapeutics AG annual total current assets?
The current annual current assets of CRSP is $1.91 B
What is the all time high annual current assets for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total current assets is $2.42 B
What is CRISPR Therapeutics AG annual current assets year-on-year change?
Over the past year, CRSP annual total current assets has changed by +$55.05 M (+2.97%)
What is CRISPR Therapeutics AG quarterly total current assets?
The current quarterly current assets of CRSP is $1.94 B
What is the all time high quarterly current assets for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total current assets is $2.62 B
What is CRISPR Therapeutics AG quarterly current assets year-on-year change?
Over the past year, CRSP quarterly total current assets has changed by +$35.81 M (+1.88%)